NDAORALTABLET, DELAYED RELEASE
Approved
Dec 2007
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Data completeness
4/8 — Partial
OMEPRAZOLE (omeprazole) by Bridge Therapeutics is proton pump inhibitors [moa]. First approved in 2007.
Drug data last refreshed 14h ago · AI intelligence enriched 20h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Omeprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion by inhibiting H+/K+-ATPase in parietal cells. It is used to treat gastroesophageal reflux disease (GERD), peptic ulcer disease, and other acid-related conditions. The drug works by irreversibly blocking the final step of gastric acid production.
Peak3.4 years to LOE
Product is in peak commercial maturity with high competitive pressure (8/10), suggesting stable but consolidating team structures and focus on cost management and market defense.
Mechanism of Action
Proton Pump Inhibitors
Pharmacologic Class:
Proton Pump Inhibitor
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants
Started Jul 2026
30 enrolled
Healthy Participants
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
Started Oct 2025
28 enrolled
Healthy Adult Participants
A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55
Started Sep 2025
22 enrolled
Healthy Volunteer
Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal
Started Sep 2025
4 enrolled
Digestive HealthGastrointestinal Health
A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
Started May 2025
36 enrolled
Healthy
Worked on OMEPRAZOLE at Bridge Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.